In primary melanomas, positive COX2 immunoreactivity was significantly related to advanced Clark levels (P = .004), but no other clinicopathologic variables such as tumor growth pattern, p53 immunoreactivity, and Ki-67 labeling index. The gene discussed is PTGS2; the disease is melanoma.